| Catalog Number |
94155 |
| Medical Device Problem Code |
Improper or Incorrect Procedure or Method (2017)
|
| Health Effect - Clinical Code |
Obstruction/Occlusion (2422)
|
| Date of Event |
08/02/2022
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
Healthcare professional reported patient was injected with 0.2ml of juvéderm® ultra plus xc in the nlf and possibly experienced vascular compromise during injection.Patient was treated with hylenex, viagra, steroids, topical nitropaste, aspirin and ¿hyperbaric o2theca¿ same day.Symptoms fully resolved the next day.
|
| |
|
Additional Manufacturer Narrative
|
|
The filler was injected into the patient and is not accessible for return.The syringe has been discarded.The event is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.This is a known potential adverse event addressed in the product labeling.
|
| |
|
Search Alerts/Recalls
|